Table 1.
Clinical characteristics, hematological and biochemical parameters of COVID-19 patients with or without candiduria
| COVID-19 (n=31) | COVID-19 and candiduria (n=18) | P value | |
|---|---|---|---|
| Patient characteristics | |||
| Age (years) | 62.87 ± 14.23 | 64.83 ± 13.03 | 0.634 |
| Female gender | 15 (48.38%) | 10 (55.56%) | 0.769 |
| Use of corticosteroids | 14 (45.16%) | 13 (72.22%) | 0.082 |
| Use of antibacterials | 27 (87.10%) | 17 (94.44%) | 0.639 |
| Number of antibacterials | 2.24 ± 1.28 | 5.28 ± 2.02 | <0.0001 |
| Co-morbidities | |||
| Diabetes | 13 (41.94%) | 10 (55.56%) | 0.390 |
| Hypertension | 20 (64.51%) | 4 (22.22%) | 0.007 |
| Biochemical/hematological data | |||
| Serum creatinine (mg/dL) | 1.27 ± 0.99 | 2.37 ± 1.46 | 0.002 |
| Urea (mg/dL) | 75.77 ± 49.88 | 125.00 ± 51.34 | 0.006 |
| Hemoglobin (g/dL) | 12.39 ± 2.08 | 10.02 ± 2.73 | 0.001 |
| Platelet count (/mm3) | 273533 ± 98859 | 215333 ± 132144 | 0.041 |
| Inflammatory parameters | |||
| Leukocytes count (/mm3) | 12803 ± 12419 | 13889 ± 9838 | 0.406 |
| C-reactive protein (mg/L) | 94.48 ± 90.19 | 162.90 ± 111.10 | 0.023 |
| Lactate dehydrogenase (mM/L) | 1.46 ± 0.45 | 1.55 ± 0.85 | 0.821 |
| Outcome | |||
| Length of hospital stay (days) | 12.48 ± 5.82 | 34.44 ± 22.99 | <0.001 |
| In-hospital mortality | 9 (29.03%) | 14 (77.78%) | 0.001 |
In bold, significantly different parameters between the two groups of patients